CHOLAC Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cholac, and what generic alternatives are available?
Cholac is a drug marketed by Alra and is included in one NDA.
The generic ingredient in CHOLAC is lactulose. There are twenty drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the lactulose profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cholac
A generic version of CHOLAC was approved as lactulose by PHARM ASSOC on July 30th, 1996.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CHOLAC?
- What are the global sales for CHOLAC?
- What is Average Wholesale Price for CHOLAC?
Summary for CHOLAC
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 28 |
| Clinical Trials: | 1 |
| Patent Applications: | 3,586 |
| DailyMed Link: | CHOLAC at DailyMed |
Recent Clinical Trials for CHOLAC
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Tampa General Hospital | Phase 4 |
US Patents and Regulatory Information for CHOLAC
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alra | CHOLAC | lactulose | SOLUTION;ORAL, RECTAL | 071331-001 | Jul 26, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
